Diagnosis of Coronary No-Reflow in the Cath Lab
Coronary no-reflow is diagnosed in the cath lab primarily through angiographic assessment of TIMI flow grade and myocardial blush grade, with TIMI flow <3 or TIMI flow 3 with myocardial blush grade 0-1 being the definitive diagnostic criteria, along with <70% ST-segment resolution within 4 hours of the procedure. 1, 2
Primary Diagnostic Criteria
Angiographic Assessment
TIMI Flow Grade:
- TIMI 0: No antegrade flow beyond occlusion point
- TIMI 1: Contrast passes beyond obstruction but "hangs up" and fails to opacify entire coronary bed
- TIMI 2: Slower contrast entry/clearance compared to normal vessels
- TIMI 3: Normal antegrade flow and clearance
Myocardial Blush Grade (MBG):
Electrocardiographic Assessment
- ST-segment resolution <70% within 4 hours of the procedure despite successful epicardial artery opening 1
Additional Diagnostic Methods in the Cath Lab
Direct Invasive Assessment
- Coronary Flow Velocity Measurement:
Timing of Diagnosis
- No-reflow typically develops within the first 2 hours of reperfusion 4
- Incidence ranges from 10-40% of patients undergoing reperfusion therapy for STEMI 1, 2
Clinical Significance and Implications
- No-reflow is associated with:
Differential Considerations
- Differentiate persistent slow flow or no-reflow from competitive flow from remaining collateral channels 1
- TIMI grade 2 flow after CTO-PCI is considered a successful result and should be differentiated from slow reflow with evidence of ongoing ischemia 1
Post-Cath Lab Confirmation
While not part of the initial cath lab diagnosis, these methods can confirm and quantify no-reflow:
- Non-invasive imaging techniques:
Practical Approach to Diagnosis
- Assess TIMI flow grade immediately after intervention
- If TIMI flow is <3, diagnose as no-reflow
- If TIMI flow is 3, assess myocardial blush grade
- If MBG is 0-1 despite TIMI 3 flow, diagnose as no-reflow
- Monitor ST-segment resolution within 4 hours of the procedure
- Consider Doppler guidewire assessment for borderline cases
By following this systematic approach, coronary no-reflow can be promptly diagnosed in the cath lab, allowing for timely intervention with intracoronary vasodilators or other appropriate therapies to potentially improve outcomes 1, 2.